Zusammenfassung
Angesichts der Bedrohung, die es bedeutet an Krebs zu leiden, ist die erste Reaktion meist Schock und Bestürzung, gefolgt vom Bedürfnis, sich zu orientieren. Der emotionale Verlauf dieser Reaktion kann — je nach Schweregrad der Krankheit und Persönlichkeit — von begründeter Betroffenheit und Angst bis hin zu Panik reichen. Im folgenden beginnt der Einzelne Möglichkeiten und Wege der Bewältigung der Krankheit zu überlegen. Anfängliche Bewältigungsreaktionen wie Verzweiflung und Hilflosigkeit können neuroendokrinologische Prozesse auslösen, die genau jene Immunmechanismen schwächen, die der einzelne braucht, um bösartige Tumore und Mikrometastasen unter Kontrolle zu bekommen. Umgekehrt scheint positives Bewältigungsverhalten mitzuhelfen, das Immunsystem ständig aktiv zu autineoplastischen und zytotoxischen Aktivitäten anzuregen und so das Fortschreiten des Krebses nicht zu fördern.
Übersetzung aus dem Englischen von C. Pawlowsky, Wien. Mit freundlicher Genehmigung der AutorInnen und des Verlages (aus: Advances 13/1, 1997)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aarstead JH, et al (1991) The effect of stress in vivo on the function of mouse macrophages in vitro. Scand J Immunol 33: 673 – 81
Adler NE, et al (1994) Socioeconomic status and health: the challenge of the gradient. Am Psychol 49: 15 – 24
Andrykowsky MA, et al (1994) Psychosocial factors predictive of survival after allogeneic bone marrow transplantation for leukemia. Psychosom Med 56: 432 – 9
Baltrusch JJ, et al (1991) Stress, cancer and immunity: new developments in biopsycho- social and psychoneuroimmunologic research. Acta Neurol 13: 315 – 27
Beecher HK (1959) Measurement of subjective responses: quantitative effects of drugs. Oxford University Press, New York [cited in: Sterling P, Eyer J (1981) Biological basis of mortality. Soc Sci Med 15: 3–42]
Benedict S (1989) The suffering associated with lung cancer. Cancer Nurs 12: 34—40
Block KI (1993) Dietary impact on quality and quantity of life in cancer patients. In: Quillan P, Williams RM (eds) Adjuvant nutrition in cancer treatment. Cancer Treatment Research Foundation (American College of Nutrition), Arlington Heights, IL, pp 99 – 127
Block KI, Gyllenhaal C, Block P (1995) Living with cancer: a pilot study of long-term survivors. NOHA News (Nutrition for Optimal Health Association) 20 (1): 6—12
Borne HW, et al (1986) Self-help in cancer patients: a review of studies on the effects of contacts between fellow patients. Patient Education and Counseling 8: 367 – 85
Borysenko J (1985) Healing motives: an interview with David C. McClelland. Advances 2 (2): 29 – 41
Buddeberg C, et al (1991) Coping strategies and course of disease of breast cancer patients. Psychother Psychosom 55: 151 – 7
CDPRG (Coronary Drug Project Research Group) (1980) Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 303: 1, 038 – 41
Cassileth BR, et al (1988) Psychosocial correlates of cancer survival: a subsequent report 3 to 8 years after cancer diagnosis. J Clin Oncol 6 (11): 1, 753 – 9
Catalona WJ (1994) Management of cancer of the prostate. N Engl J Med 331 (15): 996-1, 003
Cella DF, Cherin EA (1988) Quality of live during and after cancer treatment. Compr Ther 14: 69 – 75
Cella DF, et al (1991) Socioeconomic status and cancer survival. J Clin Oncol 9: 1, 500–9
Chiapelli F, et al (1991) Diffenrential effect of Betaendorphin on three human cytotoxic cell populations. Int J Immunopharmacol 13: 291–7
Coates A, et al (1992) The Australian New Zealand Breast Cancer Trials Group: prognostic value of quality-of-life scores during chemotherapy for advanced breast cancer. J Clin Oncol 10: 1, 833–8
Coates A, et al (1993) Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma. Eur J Cancer 29A: 1, 731–4
Commentary (1996) Many patients said to leave their MD’s office without understanding what they’ve been told. Oncology 9 (11): 1, 134
Cooper CL, Faragher EB (1993) Psychosocial stress and breast cancer: the inter-relationship between stress events, coping strategies and personality. Psychol Med 23: 652 – 62
Crowell PL, Gould MN (1994) Chemoprevention and therapy of cancer by D-limonene. Crit Rev Oncogen 5 (1): 1 – 2
De Haes JCJM (1988) Quality of life: conceptual and theoretical considerations. In: Watson, et al (eds) Psychosocial oncology. Pergamon, Oxford, pp 61–70
Dean C, Surtees PG (1989) Do psychological factors predict survival in breast cancer? J Psychosom Res 33 (5): 561–9
Downer JM, et al (1994) Pursuit and practice of complementary therapies by cancer patients receiving conventional treatment. Br Med J 309: 86–9
Dufault K, Martocchio B (1985) Hope: its spheres and dimensions. Nurs Clin North Am 20 (2): 379 – 91
Dunkel-Schetter C, et al (1992) Patterns of coping in cancer. Health Psychol 11 (2): 79 – 87
Eisenberg JM (1995) Historical and methodological perspectives on cancer outcomes research. Oncology 9 [Suppl 11]: 23–32
Epstein LH (1984) The direct effect of compliance on health outcome. Health Psych: 385 – 93
Epstein M (1996) Thougts without a thinker. Harper Collins, New York
Fallowfield LJ, et al (1990) Psychological outcomes of different treatment policies in woman with early breast cancer outside a clinical trial. Br Med J 301: 575 – 80
Fawzy FI, et al (1993) Malignant melanoma: effects of an early structured psychiatric intervention, coping and affective state on recurrence and survival 6 years later. Arch Gen Psychiatry 50: 681 – 9
Fawzy FI, et al (1995) Critical review of psychosocial interventions in cancer care. Arch Gen Psychiatry 52: 100 – 13
Foster H (1988) Lifestyle changes and the spontaneous regression of cancer: an initial computer analysis. Int J Biosoc Res 10 (1): 17–33
Fox B (1995) The role of psychological factors in cancer incidence and prognosis. Oncology 9 (3): 245 – 53
Fuller R, et al (1983) Compliance with disulfiram treatment of alcoholism. J Chronic Dis 36: 161 – 70
Ganz PA, et al (1991) Quality of life assessment: an independent prognostic variable for survival in lung cancer. Cancer 67: 3, 131 – 5
Glanz K, Lerman C (1992) Psychological impact of breast cancer: a critical review. Ann BehavMed 14: 204 – 12
Greer S (1991) Psychological response to cancer and survival. Psychol Med 21: 43 – 9
Greer S (1994) Psycho-oncology: its aims, achievements, and future tasks. Psycho-Oncology 3: 87 – 101
Greer S, Morris T (1979) Psychological attributes of women who develop breast cancer: a controlled study. J Psychosom Res 19: 147 – 53
Greer S, et al (1992) Adjuvant psychological therapy for patients with cancer: a prospective, randomized trial. Br Med J 304: 675 – 80
Haag JD, et al (1992a) Enhanced inhibition of protein isoprenylation and tumor growth by perillyl alcohol, an hydroxylated analog of D-limonene. Proc Am Assoc Cancer Res 33: 524
Haag JD, et al (1992b) Limonene-induced regression of mammary carcinomas. Cancer Res 52: 4, 021
Harpham WS (1995) Psychosocial oncology: a view from the other end of the stetho¬scope. J Psychosoc Oncol 13 (3): 89–105
Harrington A (1995) Probing the secrets of placebos. Alternative & Complementary Therapies 9 (10): 299–304
Higgins ET (1987) Self-discrepancy: a theory relating self and affect. Psychol Rev 93: 319 – 40
Hitch PJ, et al (1994) Effectiveness of self-help and support groups for cancer patients: a review. Psychology and Health 9: 437–48
Hogarty GE, et al (1973) Drug and sociotherapy in the aftercare of schizophrenic patient: one year relapse rates. Arch Gen Psychiatry 28: 54–64
Holland JC, Rowland JH (1987) Psychological reactions to breast cancer and its treat¬ment. In: Harris CL, Hellman S (eds) Breast disease. Lippincott, Philadelphia, pp 632 – 47
Holland JC, Rowland JH (eds) (1989) Handbook of Psycho-oncology. Oxford, New York
Horvath P (1988) Placebos and common factors in two decades of psychotherapeutic research. Psychol Bull 104: 214 – 25
Ilnyckyj A, et al (1994) A randomized controlled trial of psychotherapeutic intervention in cancer patients. Ann R Coll Phys Surg Canada 27: 93 – 6
Jamison RN, et al (1987) Psychogenic factors in predicting survival of breast cancer patients. J Clin Oncol 5: 768 – 72
Jamner L, et al (1988) The relationships between repressive and defensive coping styles and monocyte, eosinophil, and serum glucose levels: support for the opioid peptide hypothesis of repression. Psychosom Med 50: 567 – 75
Kahn DL, Steeves RH (1995) The significance of suffering in cancer care. Semin Oncol Nursing 11 (1): 9 – 16
Kastin A, et al (1991) Failure of met-enkephalin to enhance natural killer cell activity. Immunobiology 183: 55 – 68
Kiebert GM, et al (1991) The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: a review. J Clin Oncol 9: 1, 059 – 70
Kraut R, Greenberg A (1986) Effects of endogenous and exogenous opioids on splenic natural killer cell activity. Nat Immun Cell Growth Regul 5: 28 – 40
Kreitler S, et al (1993) Repressiveness: cause or result of cancer? Psycho-oncology 2: 43 – 54
Laudenslager M, et al (1983) Coping and immunosuppression: inescapable but not escapable shock suppresses lymphocyte proliferation. Science 221: 568 – 70
Lerner M (1994) Choices in healing. MIT Press, Cambridge, MA
Levy S, et al (1988) Survival hazards in first recurrent breast cancer patients: seven-year follow-up. Psychosom Med 50: 520–8
Levy S, et al (1991) Persistently low natural killer cell activity and circulating levels of plasma beta endorphin risk factors for infectious disease. Life Sci 48: 107 – 16
Linn M, et al (1982) Effects of counseling for late-stage cancer patients. Cancer 49: 1, 048 –55
Maunsell E, et al (1995) Social support and survival among women with breast cancer. Cancer 76: 631 – 7
Messina MJ, et al (1994) Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutrition & Cancer 21 (2): 113 – 31
O’Connor SM (1986) Commitment in cancer patients: a phenomenological study. Diss Abstr Int Sci 46 (8): 2, 618
Office of Technology Assessment (1978) PB 286/929. U.S. Congress, Office of Technology Assessment
O’Regan B, Hirshberg C (1993) Spontaneous remmission. Institute for Noetic Sciences, Sausalito, CA
Oh VMS (1994) The placebo effect: can we use it better? Br Med J 309: 69 – 70
Peteet JR, et al (1992) Emotional support for patients with cancer who are undergoing CT: semistructured interviews of patients at a cancer institute. Radiology 182 (1): 99 – 101
Pizzo PA, et al (1983) Oral antibiotic prophylaxis in patients with cancer: a double-blind randomized placebo controlled trial. J Pediatr 102: 125 – 33
Poncar PJ (1994) Inspiring hope in the oncology patient. J Psychosoc Nurs 32 (1): 33 – 8
Reele BL (1994) Effect of counseling on quality of life for individuals with cancer and their families. Cancer Nursing 17 (2): 101 – 12
Reynolds P, Kaplan GA (1990) Social connections and risk of cancer: prospective evidence from the alameda county study. Behav Med 16: 101 – 10
Richardson JL, et al (1990) The effect of compliance with treatment on survival among patients with hematologic malignancies. J Clin Oncol 8: 356 – 64
Richardson JL, et al (1991) Does psychological status influence cancer patient survival? A case still in need of evidence. In: Lewis CE, O’Sullivan C, Barraclough J (eds) The psychoimmunology of cancer. Oxford University Press, New York, pp 228–45
Riel-Emde A, et al (1989) Ursachenatribution und Krankheitsbewaltigung bei Patient- innen mit Mammakarzinom. Psychother Med Psychol 39: 232–38 [cited in: Buddeberg C, et al (1991)]
Roud PC (1985) Psychological variables associated with the exceptional survival of ter¬minally ill cancer patients. Diss Abstr Int Sci 46 (6): 2, 051
Ruckdeschel JC, Piantodsi S (1989) Assessment of quality of life by the functional living index-cancer (FLI-C) is superior to performance status for prediction of survival in patients with lung cancer. Proc Am Soc Clin Oncol 8: 311 (Abstr)
Ruckdeschel JC, et al (1991) Quality of life assessment in lung surgery for bronchogenic carcinoma. J Thor Surg 6: 201 – 5
Schulz R, et al (1995) The psychological, social, and economic impact of illness among patients with recurrent cancer. J Psychosoc Oncol 13 (3): 21–45
Shavin Y, et al (1984) Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity. Science 223: 188 – 223
Spiegel D (1990) Can psychotherapy prolong cancer survival? Psychosomatics 31 (4): 361 – 5
Spiegel D (1990) Facilitating emotional coping during treatment. Cancer 66: 1, 422–60 Spiegel D (1993) Living beyond limits: new help and hope for facing life-threatening illness. Random House, New York
Spiegel D (1994) Health caring: psychosocial support for patients with cancer. Cancer 74: 1, 453 – 7
Spiegel D (1996) The fox article reviewed. Oncology 9 (3): 253 – 4
Spiegel D, et al (1981) Group support for patients with metastatic breast cancer. Arch Gen Psychiatry 38: 527
Spiegel D, et al (1989) Effect of psychosocial treatment on survival of patients with meta-static breast cancer. Lancet: 888 – 91
Temoshok L, Dreher H (1993) The type C connection. Random House, New York
Temoshok L, et al (1985) Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophy- siology and tumor-host response. Soc Sci Med 20: 833 – 40
Wise B (1987) Comparison of immune response to mirth and distress in women at risk for recurrent breast cancer. Thesis, University of Pittsburgh [cited in: Levy, et al (1988)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag/Wien
About this paper
Cite this paper
Block, K.I. (1997). Die Rolle des Selbst beim gesunden Überleben einer Krebserkrankung: Die Perspektive aus der vordersten Front der Krebsbehandlung. In: Jahrbuch der Psychoonkologie. Jahrbuch der Psychoonkologie, vol 1997. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6883-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6883-7_1
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83068-0
Online ISBN: 978-3-7091-6883-7
eBook Packages: Springer Book Archive